Impact of new sexually transmitted disease diagnostics on clinical practice and public health policy
Tóm tắt
Nucleic acid amplification tests (NAAT) offer enhanced sensitivity and excellent specificity for many sexually transmitted diseases. For some pathogens for which a practical diagnostic test does not exist, such as human papillomavirus (HPV), NAAT are also useful. Further, most NAAT can be applied to less "invasive" patient specimens, including urine and vaginal fluid. This dramatically increases opportunities to test persons outside of traditional clinic settings. Use of NAAT has resulted in revisions of the proportion of sexually transmitted diseases (STDs) that are asymptomatic, and has increased measured prevalence of some STDs, notably Chlamydia trachomatis. NAAT have helped to clarify the eitiologies of genital ulcer disease and urethritis, and have provided a more complete picture of the natural history of genital herpes and HPV. The ability of polymerase chain reaction to detect HPV may change the management of patients who have abnormal Pap smears. Efforts to bear the relatively high cost of NAAT, such as pooling urine, are under study. NAAT for bacterial STD should be in populations at high risk for asymptomatic STD, especially those who might not access routine STD screening at traditional settings. Working through the cost to health care systems, including the public health arena, and implementation at the laboratory level are challenges to overcome before NAAT become the standard of care in most settings.
Tài liệu tham khảo
Black CM, Morse SA: The use of molecular techniques for the diagnosis and epidemiologic study of sexually transmitted infections. Curr Infect Dis Rep 2000, 2:31–43.
Black CM: Current methods of laboratory diagnosis of Chlamydia trachomatis infections. Curr Microbiol Rev 1997, 10:160–184.
Lee HH, Chernesky MA, Schachter J, et al.: Diagnosis of Chlamydia trachomatis genitourinary infection in women by ligase chain reaction assay of urine. Lancet 1995, 345:213–216.
Quinn TC, Welsh L, Lentz A, et al.: Diagnosis by AMPLICOR PCR of Chlamydia trachomatis infection in urine samples from women and men attending sexually transmitted disease clinics. J Clin Microbiol 1996, 34:1401–1406.
Schachter J, Stamm WE, Quinn TC, et al.: Ligase chain reaction to detect Chlamydia trachomatis infection of the cervix. J Clin Microbiol 1994, 32:2540–2543.
Hook EW 3d, Smith K, Mullen C, et al.: Diagnosis of genitourinary Chlamydia trachomatis infections by using the ligase chain reaction on patient-obtained vaginal swabs. J Clin Microbiol 1997, 35:2133–2135. This is the first report of self-collected vaginal swabs for the detection of C. trachomatis by LCR, an approach that could facilitate the mailing of specimens from remote sites or by women who otherwise might not have access to diagnostic testing.
Ostergaard L, Andersen B, Olesen F, et al.: Efficacy of home sampling for screening of Chlamydia trachomatis: randomised study. BMJ 1998, 317:26–27.
Xu K, Glanton V, Johnson SR, et al.: Diagnosis of Neisseria gonorrhoeae infection by ligase chain reaction testing of urine among adolescent women with and without Chlamydia trachomatis infection. Sex Transm Dis 1998, 25:533–538.
Hook EW 3d, Ching SF, Stephens J, et al.: Diagnosis of Neisseria gonorrhoeae in women by using ligase chain reaction on patient-obtained vaginal swabs. J Clin Microbiol 1997, 35:2129–2132.
Marrazzo JM, Whittington WL, Celum CL, et al.: Urine-based screening for Chlamydia trachomatis in men attending sexually transmitted disease clinics. Sex Transm Dis 2001, in press.
Marrazzo JM, Stamm WE: New approaches to the diagnosis, treatment, and prevention of chlamydial infection. In Current Clinical Topics in Infectious Diseases, edn 18. Edited by Remington JS, Swartz MN. Boston: Blackwell Science; 1998:37–59.
Division of STD Prevention: Sexually Transmitted Disease Surveillance 1998 Supplement, Chlamydia Prevalence Monitoring Project. Atlanta: Centers for Disease Control and Prevention; 1999.
Dicker LW, Mosure DJ, Levine WC, et al.: Impact of switching laboratory tests on reported trends in Chlamydia trachomatis infections. Am J Epidemiol 2000, 151:430–435.
Orle KA, Gates CA, Martin DH, et al.: Simultaneous PCR detection of Haemophilus ducreyi, Treponema pallidum, and herpes simplex viruses types-1 and -2 from genital ulcers. J Clin Microbiol 1996, 34:49–54. This study first described the application of the multiplex PCR test to distinguish among the major causes of genital ulcer disease. It also confirmed that clinical diagnosis is unreliable in making a specific microbiological diagnosis.
Morse SA, Trees DL, Htun Y, et al.: Comparison of clinical and standard laboratory and molecular methods for the diagnosis of genital ulcer disease in Lesotho: association with human immunodeficiency virus infection. J Infect Dis 1997, 175:583–589.
Krieger JN, Jenny C, Verdon M, et al.: Clinical manifestations of trichomoniasis in men. Ann Intern Med 1993, 118:844–849.
Madico G, Quinn TC, Rompalo A, et al.: Diagnosis of Trichomonas vaginalis infection by PCR using vaginal swab samples. J Clin Microbiol 1998, 36:3205–3210. These investigators found that the sensitivities of the saline wet prep and culture were 36% and 70%, respectively, relative to PCR performed on vaginal specimens.
Gambini D, Decleva I, Lupica L, et al.: Mycoplasma genitalium in males with nongonococcal urethritis: prevalence and clinical efficacy of eradication. Sex Transm Dis 2000, 27:226–229.
Janier M, Lassau F, Casin I, et al.: Male urethritis with and without discharge: a clinical and microbiological study. Sex Transm Dis 1995, 22:244–252.
Centers for Disease Control and Prevention: 1998 Sexually transmitted disease surveillance report. Available on line at http://www.cdc.gov
Marrazzo JM, White CL, Lafferty WE, et al.: Community-based urine screening for Chlamydia trachomatis infection by ligase chain reaction. Ann Intern Med 1997, 127:796–803.
Cohen DA, Nsuami M, Etame RB, et al.: A school-based Chlamydia control program using DNA amplification technology. Pediatrics 1998, 101:E1.
Rietmeijer CA, Yamaguchi KJ, Ortiz CG, et al.: Feasibility and yield of screening urine for Chlamydia trachomatis by polymerase chain reaction among high-risk male youth in field-based and other nonclinic settings. Sex Transm Dis 1997, 24:429–435.
Ellen JM, Lane MA, McCright H: Are adolescents being screened for sexually transmitted diseases? Sex Transm Inf 2000, 76:94–97.
Gaydos CA, Howell MR, Pare B, et al.: Chlamydia trachomatis infections in female military recruits. N Engl J Med 1998, 339:739–744.
Koutsky LA: Epidemiology of genital human papillomavirus infection. Am J Med 1997, 102:3–8.
Koutsky LA, Holmes KK, Critchlow CW, et al.: A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 1992, 327:1272–1278.
Ho GY, Bierman R, Beardsley L, et al.: Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998, 338:423–428.
Manos MM, Kinney WK, Hurley LB, et al.: Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA. 1999, 281:1605–1610. Among 995 women with Pap test results showing ASCUS, the authors found that management based on HPV testing only or on repeated Pap testing only would refer similar proportions (approximately 39%) of patients to colposcopy, for an overall sensitivity for HPV testing of 97%. By having a Pap smear specimen collected at initial screening, most women at high risk for HSIL could be identified and referred for colposcopy based on a single screening
Wright TC, Denny L, Kuhn L, et al.: HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. JAMA 2000, 283:81–86. This large study, performed in 1415 South African women who had not been previously screened for cervical neoplasia, found that 68% of women with high-risk HPV types detected in self-collected vaginal swabs had an abnormal Pap smear; 66% of women with high-grade cervical neoplasia had high-risk HPV types detected on vaginal swabs.
Wald A, Zeh J, Selke S, et al.: Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N Engl J Med 2000, 342:844–850.
Bjartling C, Osser S, Persson K: The frequency of salpingitis and ectopic pregnancy as epidemiologic markers of Chlamydia trachomatis. Acta Obstet Gynecol Scand 2000, 79:123–128.
Scholes D, Stergachis A, Heidrich FE, et al.: Prevention of pelvic inflammatory disease by screening for cervical chlamydia infection. N Engl J Med 1996, 334:1362–1366.
Kacena KA, Quinn TC, Brathwaite W, et al.: Pooling urine samples for ligase chain reaction screening for genital Chlamydia trachomatis infection in asymptomatic women. J Clin Microbiol 1998, 36:481–485. This study evaluated whether pooling urine samples for performance of LCR retained acceptable sensitivity and specificity as a function of underlying C. trachomatis prevalence. The authors concluded that pooling up to four urine specimens retains adequate sensitivity and may reduce the cost of implementing LCR in populations with moderate prevalence of chlamydial infection.
Peeling RW, Toye B, Jessamine P, et al.: Pooling of urine specimens for PCR testing: a cost saving strategy for Chlamydia trachomatis control programmes. Sex Transm Infect 1998, 74:66–70.